Concepedia

Axel Hernández

AH

Statistics

Publications

15

Citations

312

H-Index

11

Active since

1995

Affiliations

AbbVie (United States)(Current)

Nanjing Forestry University

WuXi AppTec (China)

Université de Corse Pascal Paoli

Tianjin Economic-Technological Development Area

Axel Hernández is an author at AbbVie (United States) specializing in antibody-drug conjugates, antibody conjugates, and pharmacy.

ORCID

Publications per year

1995–2024

15

Publications

15

Design and Development of Glucocorticoid Receptor Modulators as Immunology Antibody–Drug Conjugate Payloads

Adrian D. Hobson, Michael J. McPherson, Wendy Waegell et al. · Journal of Medicinal Chemistry · 2022 · 41 citations

, , +17

Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate

Adrian D. Hobson, Michael J. McPherson, Martin E. Hayes et al. · Journal of Medicinal Chemistry · 2022 · 40 citations

, , +17

Genomic phylogeography illuminates deep cyto-nuclear discordances in midwife toads (Alytes)

Johanna Ambu, Í‪ñigo Martínez-Solano, Tomasz Suchan et al. · Molecular Phylogenetics and Evolution · 2023 · 33 citations · Full text

, , +12

An anti–TNF–glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases

Michael Mcpherson, Adrian D. Hobson, Axel Hernández et al. · Science Translational Medicine · 2024 · 27 citations

, , +17

Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)

Adrian D. Hobson, Jianwen Xu, Dennie S. Welch et al. · Journal of Medicinal Chemistry · 2023 · 26 citations

, , +17

1–5 of 15